Is there any Effect of Intracavitary Therapy for Superficial Bladder Tumors on Urethral Strictures?
Objectives: In this study, we aimed to find the answer to the question of whether intracavitary therapy administered for bladder tumor has any effect on the development of urethral strictures.
Methods: The patients who underwent transurethral resection of the bladder with the diagnosis of bladder tumor in our clinic were divided into two as the group with urethral strictures and the group without urethral strictures. Intracavitary therapies, follow-up, and recurrence data of the patients of both groups were recorded.
Results: The mean age of the patients with and without urethral stricture was 67.8 and 68.4 years, respectively. There was no significant difference between the T staging and grading of patients in the two groups. There was no statistically significant difference between the patients with and without urethral stricture in terms of intracavital therapy rates (p=0.943).
Conclusion: Although we demonstrated that intracavitary therapy administered for bladder tumors had no effect on the development of urethral strictures, we believe we need randomized controlled trials with larger patient series.
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0: Estimated Cancer İncidence, Mortality and Prevalence Worldwide in 2012. 2013. 2015. Geneva: World Health Organization; 2015.
2. American Cancer Society. Cancer Facts and Figures 2005, Atlanta: American Cancer Society; 2005.
3. Catalona WJ. Urothelial tumors of the urinary tract. In: Walsh P, Retik AB, Stamey TA, Vaughan ED, editors. Campbell’s Urology. 6th ed. Philadelphia, PA: WB Saunders; 1992. p. 1094–136.
4. Tolley DA, Parmar MK, Grigor KM, Lallemand G, Benyon LL, Fellows J, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: A further report with 7 years of follow up. J Urol 1996;155:1233–8.
5. Böhle A, Bock PR. Intravesical bacille calmette-guérin versus mitomycin C in superficial bladder cancer: Formal meta-analysis of comparative studies on tumor progression. Urology 2004;63:682–6. [CrossRef]
6. Liu H, Wu J, Xue S, Zhang Q, Ruan Y, Sun X, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res 2013;41:984–92. [CrossRef]
7. Liaqat Ali, Muhammad Shahzad, Nasir Orakzai, Ihsanullah Khan, Mubashira Ahmad. Efficacy of mitomycin C in reducing recurrence of anterior urethral stricture after internal optical urethrotomy. Korean J Urol 2015;56:650–5. [CrossRef]
8. Farrell MR, Sherer BA, Levine LA. Visual internal urethrotomy with intralesional mitomycin C and short-term clean intermittent catheterization for the management of recurrent urethral strictures and bladder neck contractures. Urology 2015;85:1494–9. [CrossRef]
9. Liem EIML, McCormack M, Chan ESY, Matsui Y, Geavlete P, Choi YD, et al. Monopolar vs. Bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial. Urol Oncol 2018;36:338. e1-0000000000. [CrossRef]
10. Rodríguez FM, Chéchıle-Tonıolo G, Salvador-Bayarrı J, Palou J, Vıcente-Rodríguez J. Multıvarıate analysıs of the prognostıc factors of prımary superfıcıal bladder cancer. J Urol2000;163:73–8. [CrossRef]
11. Nielsen KK, Nordling J. Urethral stricture following transurethral prostatectomy. Urology 1990;35:18–24. [CrossRef]
12. Hammarsten J, Lindqvist K, Sunzel H. Urethral strictures following transurethral resection of the prostate. The role of the catheter. Br J Urol 1989;63:397–400. [CrossRef]
13. Hart AJ, Fowler JW. Incidence of urethral strictures following transurethral prostatectomy: Review of 2223 resections. J Urol 1997;117:194–201.
14. Hebert PW. The treatment of urethral stricture: Transurethral injection of triamcinolone. J Urol 1972;108:745–7. [CrossRef]
15. Hosseini J, Kaviani A, Golshan AR. Clean intermittent catheterization with triamcinolone ointment following internal urethrotomy. Urol J 2008;5:265–8.
16. Mazdak H, Meshki I, Ghassami F. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur Urol 2007;51:1089–92. [CrossRef]
17. Vanni AJ. New frontiers in urethral reconstruction: Injectables and alternative grafts. Transl Androl Urol 2015;4:84–91.
18. Donin NM, Lenis AT, Holden S, Drakaki A, Pantuck A, Belldegrun A, et al. Immunotherapy for the treatment of urothelial carcinoma. J Urol 2017;197:14–22. [CrossRef]